Comparison of immediate and sustained release formulations of lithium salts

References

• Alda, M. (2006). Pharmacokinetics of lithium. In M. Bauer, P. Grof, & B. Müller-Oerlinghausen (Eds.), Lithium in neuropsychiatry – The comprehensive guide (pp. 321–328). Informa Healthcare.
   Google Scholar
• Alda, M. (2015). Lithium in the treatment of bipolar disorder: Pharmacology and pharmacogenetics. Molecular Psychiatry, 20(6), 661–670. https://doi.org/10.1038/mp.2015.4
   PubMed Web of Science ®Google Scholar
• Baldessarini, R. J. (2013). Chemotherapy in psychiatry. Springer Press.
   Google Scholar
• Baldessarini, R. J., Tondo, L., & Vázquez, G. H. (2021). Lithium treatment for bipolar disorder. Bipolar Disorders, 23(1), 93–94. https://doi.org/10.1111/bdi.12997
   PubMed Web of Science ®Google Scholar
• Barbuti, M., Colombini, P., Ricciardulli, S., Amadori, S., Gemmellaro, T., De Dominicis, F., Della Rocca, F., Petrucci, A., Schiavi, E., & Perugi, G. (2021). Treatment adherence and tolerability of immediate- and prolonged-release lithium formulations in a sample of bipolar patients: A prospective naturalistic study. International Clinical Psychopharmacology, 36(5), 230–237. https://doi.org/10.1097/YIC.0000000000000373
   PubMed Web of Science ®Google Scholar
• Bowden, C. L. (1998). Key treatment studies of lithium in manic-depressive illness: Efficacy and side effects. Journal of Clinical Psychiatry, 59(Suppl. 6), 13–19.
   Google Scholar
• Carter, L., Zolezzi, M., & Lewczyk, A. (2013). An updated review of the optimal lithium dosage regimen for renal protection. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie, 58(10), 595–600. 10.1177/070674371305801009 24165107
   PubMed Web of Science ®Google Scholar
• Castrogiovanni, P. (2002). A novel slow-release formulation of lithium carbonate (carbolithium once-a-day) vs. standard carbolithium: a comparative pharmacokinetic study. La Clinica Terapeutica, 153(2), 107–115.
   PubMedGoogle Scholar
• Cooper, T. B., Simpson, G. M., Lee, J. H., & Bergner, P. E. (1978). Evaluation of a slow-release lithium carbonate formulation. The American Journal of Psychiatry, 135(8), 917–922. https://doi.org/10.1176/ajp.135.8.917
   PubMed Web of Science ®Google Scholar
• DiMatteo, M. R., Giordani, P. J., Lepper, H. S., & Croghan, T. W. (2002). Patient adherence and medical treatment outcomes: a meta-analysis. Medical Care, 40(9), 794–811. https://doi.org/10.1097/00005650-200209000-00009
   PubMed Web of Science ®Google Scholar
• Durbano, F., Mencacci, C., Dorigo, D., Riva, M., & Buffa, G. (2002). The long-term efficacy and tolerability of carbolithium once a day: an interim analysis at 6 months. Clinical Therapeutics, 153(3), 161–166.
   Google Scholar
• Fyrö, B., Pettersson, U., & Sedvall, G. (1970). Serum lithium levels and side effects during administration of lithium carbonate and two slow release lithium preparations to human volunteers. Pharmacologia Clinica, 2(4), 236–240. https://doi.org/10.1007/BF00404307
   Google Scholar
• Girardi, P., Brugnoli, R., Manfredi, G., & Sani, G. (2016). Lithium in bipolar disorder: Optimizing therapy using prolonged-release formulations. Drugs in R&D, 16(4), 293–302. https://doi.org/10.1007/s40268-016-0139-7
   PubMedGoogle Scholar
• Grandjean, E. M., & Aubry, J. M. (2009). Lithium: Updated human knowledge using an evidence-based approach: clinical safety. CNS Drugs, 23(5), 397–418. https://doi.org/10.2165/00023210-200923050-00004
   PubMed Web of Science ®Google Scholar
• Grof, P., MacCrimmon, D., Saxena, B., Daigle, L., & Prio, M. (1976). Bioavailabiltity and side effects of different lithium carbonate products. Neuropsychobiology, 2(5–6), 313–323. https://doi.org/10.1159/000117562
   PubMed Web of Science ®Google Scholar
• Miller, A. L., Bowden, C. L., & Plewes, J. (1985). Lithium and impairment of renal concentrating ability. Journal of Affective Disorders, 9(2), 115–119. https://doi.org/10.1016/0165-0327(85)90089-8
   PubMed Web of Science ®Google Scholar
• Mitchell, P. B., & Hadzi-Pavlovic, D. (2000). Lithium treatment for bipolar disorder. WHO Bulletin, 78(4), 515–517.
   PubMed Web of Science ®Google Scholar
• Moher, D., Shamseer, L., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P., & Stewart, L. A. (2015). Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews, 4(1), 1–8. https://doi.org/10.1186/2046-4053-4-1
   PubMed Web of Science ®Google Scholar
• Nolen, W. A., Licht, R. W., Young, A. H., Malhi, G. S., Tohen, M., Vieta, E., Kupka, R. W., Zarate, C., Nielsen, R. E., Baldessarini, R. J., & Severus, E. (2019). What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? Systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium. Bipolar Disorders, 21(5), 394–409. https://doi.org/10.1111/bdi.12805
   PubMed Web of Science ®Google Scholar
• Pelacchi, F., Dell’Osso, L., Bondi, E., Amore, M., Fagiolini, A., Iazzetta, P., Pierucci, D., Gorini, M., Quarchioni, E., Comandini, A., Salvatori, E., Cattaneo, A., & Pompili, M. (2022). Clinical evaluation of switching from immediate-release to prolonged-release lithium in bipolar patients poorly tolerant to lithium immediate-release treatment: A randomized clinical trial. Brain and Behavior, 12(3), e2485.
   PubMed Web of Science ®Google Scholar
• Persson, G. (1974). Plasma lithium levels and side effects during administration of a slow release lithium sulphate preparation (lithium Lipett C) and lithium carbonate tablets. Acta Psychiatrica Scandinavica, 50(2), 174–182. https://doi.org/10.1111/j.1600-0447.1974.tb08206.x
   PubMed Web of Science ®Google Scholar
• Schou, M., Amdisen, A., Thomsen, K., Vestergaard, P., Hetmar, O., Mellerup, E. T., Plenge, P., & Rafaelsen, O. J. (1982). Lithium treatment regimen and renal water handling: The significance of dosage pattern and tablet type examined through comparison of results from two clinics with different treatment regimens. Psychopharmacology, 77(4), 387–390. https://doi.org/10.1007/BF00432777
   PubMed Web of Science ®Google Scholar
• Tondo, L., Alda, M., Bauer, M., Bergink, V., Grof, P., Hajek, T., Lewitka, U., Licht, R. W., Manchia, M., Müller-Oerlinghausen, B., Nielsen, R. E., Selo, M., Simhandl, C., & Baldessarini, R. J. (2019). Clinical use of lithium salts: Guide for patients and prescribers. International Journal of Bipolar Disorders, 7(1), 16–25. https://doi.org/10.1186/s40345-019-0151-2
   PubMedGoogle Scholar
• Tondo, L., Vázquez, G. H., & Baldessarini, R. J. (2021). Prevention of suicidal behavior in bipolar disorder. Bipolar Disorders, 23(1), 14–23. https://doi.org/10.1111/bdi.13017
   PubMed Web of Science ®Google Scholar
• Undurraga, J., Sim, K., Tondo, L., Gorodischer, A., Azua, E., Tay, K. H., Tan, D., & Baldessarini, R. J. (2019). Lithium treatment for unipolar major depressive disorder: Systematic review. Journal of Psychopharmacology, 33(2), 167–176. https://doi.org/10.1177/0269881118822161
   PubMed Web of Science ®Google Scholar
• Wallin, L., & Alling, C. (1979). Effect of sustained-release lithium tablets on renal function. British Medical Journal, 2(6201), 1332. https://doi.org/10.1136/bmj.2.6201.1332
   PubMedGoogle Scholar